GALT
Galectin Therapeutics Inc
NASDAQ: GALT · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.89% today
Updated 2026-04-30
Market cap
$156.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $7
Volume
0.3M
Galectin Therapeutics Inc (GALT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.96M | $6.36M | $1.78M | $704000.00 | $436000.00 | $6.30M | $6.61M | $9.56M | $10.71M | $29.68M | $26.41M | $15.79M | $4.16M | $9.01M | $48.47M | $29.60M | $41.83M | $21.29M | $28.20M | $17.50M |
| Cash & equivalents | $4.47M | $773000.00 | $1.32M | $318000.00 | $251000.00 | $5.89M | $6.40M | $9.36M | $10.49M | $29.13M | $25.85M | $15.36M | $3.05M | $8.25M | $47.48M | $27.14M | $39.65M | $18.59M | $25.66M | $15.12M |
| Current assets | $4.69M | $5.94M | $1.39M | $380000.00 | $304000.00 | $6.20M | $6.50M | $9.52M | $10.69M | $29.66M | $26.40M | $15.79M | $3.82M | $8.83M | $48.21M | $29.46M | $41.82M | $20.55M | $27.71M | $17.25M |
| Total liabilities | $1.38M | $6.38M | $4.71M | $1.17M | $4.90M | $7.99M | $2.21M | $1.64M | $2.49M | $1.70M | $1.36M | $3.78M | $2.97M | $2.11M | $2.87M | $5.41M | $39.21M | $53.48M | $88.44M | $120.56M |
| Current liabilities | $1.38M | $5.99M | $2.60M | $1.08M | $1.05M | $1.77M | $2.21M | $1.64M | $2.49M | $1.70M | $1.36M | $3.78M | $2.97M | $2.11M | $2.82M | $5.40M | $9.03M | $13.01M | $15.68M | $35.41M |
| Long-term debt | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $29.05M | $39.83M | $71.74M | $85.11M |
| Shareholder equity | $3.58M | $-22000.00 | $-2.92M | $-469000.00 | $-4.47M | $-1.69M | $4.40M | $7.92M | $8.23M | $27.97M | $25.05M | $12.02M | $1.19M | $6.90M | $45.59M | $24.19M | $2.62M | $-32.19M | $-60.24M | $-103.07M |
| Retained earnings | $-26.43M | $-25.73M | $-35.16M | $-38.55M | $-47.72M | $-56.42M | $-69.14M | $-80.02M | $-101.97M | $-118.92M | $-140.05M | $-163.70M | $-181.17M | $-196.22M | $-216.39M | $-240.00M | $-270.69M | $-309.57M | $-354.37M | $-401.57M |
| Accounts receivable | — | — | — | — | — | $234000.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | $209000.00 | $256000.00 | $250000.00 | $225000.00 | $56000.00 | $39000.00 | $36000.00 | $30000.00 | $23000.00 | $15000.00 | $8000.00 | $1000.00 | $0.00 | — | — | — | — | — | — | — |